Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.4 |
mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.4 |
mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.25 | 0.4 |
mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.4 |